Omegga applies spectroscopy and machine learning to detect embryo sex non-invasively before incubation day 7, addressing a global animal welfare problem. The tech stack (Python, FastAPI, AWS) points to a software-first approach layered onto hardware, while active projects span electrical control systems and robotic automation—suggesting they're scaling from proof-of-concept into manufactureable product. Hiring velocity is accelerating across engineering and product, concentrated in Germany.
Omegga is a Munich-based biotech company founded in 2020 that builds an optical, non-invasive solution for determining chicken embryo sex before hatch using spectroscopy and AI. The core application targets male chick culling, a widespread animal welfare and economic problem in poultry production. The company operates across three layers: spectral data acquisition hardware, AI-driven pattern recognition, and customer-facing workflow software. Current work spans control architecture design, robotic system integration, and platform rollout to early customers.
Omegga uses optical spectroscopy combined with AI to detect chicken embryo sex inside the egg before incubation day 7, without breaking or damaging the egg. The approach is non-invasive, early-stage, and cost-effective compared to post-hatch sexing.
Python, FastAPI, Django, AWS for backend and data processing; Angular for frontend; EPLAN, EtherCAT, PROFINET, CANopen for electrical and robotic control systems; Excel, Notion, Google Sheets for operations.
Other companies in the same industry, closest in size